Cost-utility of expanded hypertension screening and treatment among adults covered by Peru's Seguro Integral de Salud: a Markov model using national data.

Vera-Ponce VJ, Ballena-Caicedo J

Open source

DOI
10.1080/14737167.2026.2751401
Published
2026 Oct 18
Container
Expert review of pharmacoeconomics & outcomes research
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1080/14737167.2026.2751401,
  title = {Cost-utility of expanded hypertension screening and treatment among adults covered by Peru's Seguro Integral de Salud: a Markov model using national data.},
  author = {Vera-Ponce VJ and Ballena-Caicedo J},
  year = {2026},
  journal = {Expert review of pharmacoeconomics \& outcomes research},
  doi = {10.1080/14737167.2026.2751401},
  url = {https://doi.org/10.1080/14737167.2026.2751401}
}

RIS

TY  - JOUR
TI  - Cost-utility of expanded hypertension screening and treatment among adults covered by Peru's Seguro Integral de Salud: a Markov model using national data.
AU  - Vera-Ponce VJ
AU  - Ballena-Caicedo J
PY  - 2026
JO  - Expert review of pharmacoeconomics & outcomes research
DO  - 10.1080/14737167.2026.2751401
UR  - https://doi.org/10.1080/14737167.2026.2751401
ER  - 

APA

VJ, V., & J, B. (2026). Cost-utility of expanded hypertension screening and treatment among adults covered by Peru's Seguro Integral de Salud: a Markov model using national data.. Expert review of pharmacoeconomics & outcomes research. https://doi.org/10.1080/14737167.2026.2751401

Source records